Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Source: Cofisem - Last Update: 2024-02-29
Key Executives
| Chief Executive Officer | |
| Chief Financial Officer | |
| General Counsel | |
| Director of Development | |
| Chief Human Resources Officer | |
| Director Research & Development |
Source: Cofisem - Last Update: 2024-02-29
Key Figures
| Millenium | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Net sales | 2,082,300 | 1,853,307 | 1,580,074 | 1,448,867 | 1,481,848 |
| Income from ordinary activities | 2,082,300 | 1,853,307 | 1,580,074 | 1,448,867 | 1,481,848 |
| Operating income | 437,326 | 490,190 | 469,016 | 465,266 | |
| Cost of financial indebtedness net | 31,306 | 16,661 | 16,449 | 13,555 | |
| Equity-accounted companies contribution to income | |||||
| Net profit from discontinued activities | |||||
| Net income | 312,336 | 385,966 | 355,027 | 368,866 | |
| Net income (Group share) | 312,336 | 385,966 | 354,984 | 368,825 | |
| Fiscal year end | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Length of fiscal year (month) | 12 | 12 | 12 | 12 | 12 |
| Currency & Unit | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands |
| Account Standards | IFRS | IFRS | IFRS | IFRS | IFRS |
Source: Cofisem - Last Update: 2024-02-29
Shareholder information
| Group-owned stock | |
| CVC Capital Partners | |
| Free float |
Source: Cofisem - Last Update: 2024-02-29
Address
Recordati
Via Matteo Civitali 1
IT-20148 Milano
Italy
Phone number: +39 (0)2 48 78 71
Fax: +39 (0)2 40 073 747
https://recordati.com/
Source: Cofisem - Last Update: 2024-02-29
Contact
Please contact MyQuestion.Italy@euronext.com for Company Profile support.